|
ENST00000585881.5
|
ENST00000585881.5_104_126_+ |
104–126 |
609.00 |
22.47 |
2.27 |
49.31 |
NSRP1-214
|
protein coding
|
prostate gland
(Tissue)
|
|
ENST00000587762.2
|
ENST00000587762.2_6337_6420_+ |
6337–6420 |
1234.00 |
6.87 |
4.61 |
100.0 |
MIR23AHG-201
|
lncRNA
|
prostate gland
(Tissue)
|
|
ENST00000587762.2
|
ENST00000587762.2_6314_6334_+ |
6314–6334 |
3384.00 |
18.83 |
12.64 |
94.03 |
MIR23AHG-201
|
lncRNA
|
prostate gland
(Tissue)
|
|
ENST00000587762.2
|
ENST00000587762.2_6462_6481_+ |
6462–6481 |
1649.00 |
9.18 |
6.16 |
89.14 |
MIR23AHG-201
|
lncRNA
|
prostate gland
(Tissue)
|
|
ENST00000587762.2
|
ENST00000587762.2_6619_6638_+ |
6619–6638 |
5446.00 |
30.31 |
20.34 |
89.21 |
MIR23AHG-201
|
lncRNA
|
prostate gland
(Tissue)
|
|
ENST00000587762.2
|
ENST00000587762.2_6619_6641_+ |
6619–6641 |
3622.00 |
20.16 |
13.53 |
83.82 |
MIR23AHG-201
|
lncRNA
|
prostate gland
(Tissue)
|
|
ENST00000591345.5
|
ENST00000591345.5_1414_1429_+ |
1414–1429 |
8.00 |
10.26 |
0.03 |
100.0 |
ODAD3-204
|
nonsense mediated decay
|
prostate gland
(Tissue)
|
|
ENST00000592790.1
|
ENST00000592790.1_3381_3401_+ |
3381–3401 |
2987.00 |
2.62 |
11.16 |
100.0 |
VMP1-217
|
retained intron
|
prostate gland
(Tissue)
|
|
ENST00000592790.1
|
ENST00000592790.1_3343_3402_+ |
3343–3402 |
288.00 |
0.25 |
1.08 |
100.0 |
VMP1-217
|
retained intron
|
prostate gland
(Tissue)
|
|
ENST00000592790.1
|
ENST00000592790.1_3343_3366_+ |
3343–3366 |
81878.00 |
71.77 |
305.78 |
79.32 |
VMP1-217
|
retained intron
|
prostate gland
(Tissue)
|
|
ENST00000595794.5
|
ENST00000595794.5_236_279_+ |
236–279 |
592.00 |
0.07 |
2.21 |
100.0 |
C19orf48P-203
|
retained intron
|
prostate gland
(Tissue)
|
|
ENST00000595794.5
|
ENST00000595794.5_236_318_+ |
236–318 |
610623.98 |
76.35 |
2280.43 |
81.63 |
C19orf48P-203
|
retained intron
|
prostate gland
(Tissue)
|
|
ENST00000595794.5
|
ENST00000595794.5_236_320_+ |
236–320 |
157697.27 |
19.72 |
588.94 |
19.97 |
C19orf48P-203
|
retained intron
|
prostate gland
(Tissue)
|
|
ENST00000595794.5
|
ENST00000595794.5_236_330_+ |
236–330 |
2323.00 |
0.29 |
8.68 |
89.69 |
C19orf48P-203
|
retained intron
|
prostate gland
(Tissue)
|
|
ENST00000595794.5
|
ENST00000595794.5_236_276_+ |
236–276 |
51.00 |
0.01 |
0.19 |
100.0 |
C19orf48P-203
|
retained intron
|
prostate gland
(Tissue)
|
|
ENST00000595794.5
|
ENST00000595794.5_230_318_+ |
230–318 |
6.00 |
0.00 |
0.02 |
100.0 |
C19orf48P-203
|
retained intron
|
prostate gland
(Tissue)
|
|
ENST00000600027.5
|
ENST00000600027.5_434_519_+ |
434–519 |
3.00 |
0.25 |
0.01 |
100.0 |
RPS11-206
|
retained intron
|
prostate gland
(Tissue)
|
|
ENST00000600027.5
|
ENST00000600027.5_441_519_+ |
441–519 |
1075.00 |
88.11 |
4.01 |
100.0 |
RPS11-206
|
retained intron
|
prostate gland
(Tissue)
|
|
ENST00000602315.3
|
ENST00000602315.3_752_771_+ |
752–771 |
3411291.00 |
70.05 |
12739.80 |
71.54 |
CARMN-209
|
lncRNA
|
prostate gland
(Tissue)
|
|
ENST00000602478.2
|
ENST00000602478.2_671_758_+ |
671–758 |
163.00 |
13.92 |
0.61 |
100.0 |
ENST00000602478
|
lncRNA
|
prostate gland
(Tissue)
|
|
ENST00000604535.1
|
ENST00000604535.1_1396_1410_+ |
1396–1410 |
766.00 |
58.25 |
2.86 |
100.0 |
PPFIA1P1-201
|
processed pseudogene
|
prostate gland
(Tissue)
|
|
ENST00000606412.1
|
ENST00000606412.1_4_67_+ |
4–67 |
642.00 |
42.04 |
2.40 |
100.0 |
SNORD114-21-201
|
snoRNA
|
prostate gland
(Tissue)
|
|
ENST00000606412.1
|
ENST00000606412.1_35_67_+ |
35–67 |
647.00 |
42.37 |
2.42 |
100.0 |
SNORD114-21-201
|
snoRNA
|
prostate gland
(Tissue)
|
|
ENST00000606510.1
|
ENST00000606510.1_2_82_+ |
2–82 |
415.00 |
53.55 |
1.55 |
100.0 |
SNORD115-40-201
|
snoRNA
|
prostate gland
(Tissue)
|
|
ENST00000606724.1
|
ENST00000606724.1_22_43_+ |
22–43 |
12503.00 |
98.26 |
46.69 |
100.0 |
MIR98-201
|
miRNA
|
prostate gland
(Tissue)
|